title: Innovative somatic treatments for depression.
abstract: This chapter will briefly review the current theories on the biochemical etiology of depression that are contributing toward the development of innovative somatic treatments. A description of clinically approved pharmacological treatments will be described in detail. Investigational pharmacological treatments that have demonstrated a high probability for general clinical use will also be discussed. Finally, a description of sleep deprivation will be included.
authors.affiliation: Department of Psychiatry, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois.
authors.forename: J M
authors.initials: JM
authors.lastname: Zajecka
authors.forename: J
authors.initials: J
authors.lastname: Fawcett
mesh_terms: D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D011569:Psychiatric Status Rating Scales
chemical_list: D000928:Antidepressive Agents